• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:与突变相关的噬血细胞性淋巴组织细胞增生症。

Case Report: mutation-associated Hemophagocytic lymphohistiocytosis.

机构信息

Department of Hematology, Capital Medical University Affiliated Beijing Friendship Hospital, Beijing, China.

出版信息

Front Immunol. 2023 Nov 23;14:1271324. doi: 10.3389/fimmu.2023.1271324. eCollection 2023.

DOI:10.3389/fimmu.2023.1271324
PMID:38077348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10701531/
Abstract

Germline mutation has been reported to be associated with subcutaneous panniculitis-like T-cell lymphoma (SPTCL) leading to Hemophagocytic lymphohistiocytosis (HLH). Several studies have indicated that mutation can cause HLH even in the absence of lymphoma, though the exact mechanism remains unclear. In this article, we reported five cases of mutation-associated HLH. Our analysis revealed an elevated level of IL-1RA in the serum of these patients. Furthermore, we investigated the potential mechanisms underlying HLH associated with mutation based on changes in cytokine levels. Our findings suggest that mutation may represent a distinct genetic defect underlying HLH, differing from traditional primary HLH.

摘要

胚系突变已被报道与皮下脂膜炎样 T 细胞淋巴瘤(SPTCL)相关,导致噬血细胞性淋巴组织细胞增生症(HLH)。几项研究表明,即使没有淋巴瘤, 突变也能导致 HLH,尽管确切的机制尚不清楚。在本文中,我们报告了五例与 突变相关的 HLH。我们的分析显示,这些患者血清中 IL-1RA 水平升高。此外,我们还基于细胞因子水平的变化,研究了与 突变相关的 HLH 的潜在机制。我们的研究结果表明, 突变可能代表 HLH 的一种独特的遗传缺陷,与传统的原发性 HLH 不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/24e0bbc44ee5/fimmu-14-1271324-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/fc528c242d28/fimmu-14-1271324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/419262671026/fimmu-14-1271324-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/24e0bbc44ee5/fimmu-14-1271324-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/fc528c242d28/fimmu-14-1271324-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/419262671026/fimmu-14-1271324-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e24/10701531/24e0bbc44ee5/fimmu-14-1271324-g003.jpg

相似文献

1
Case Report: mutation-associated Hemophagocytic lymphohistiocytosis.病例报告:与突变相关的噬血细胞性淋巴组织细胞增生症。
Front Immunol. 2023 Nov 23;14:1271324. doi: 10.3389/fimmu.2023.1271324. eCollection 2023.
2
Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.解析皮下脂膜炎样T细胞淋巴瘤:皮下脂膜炎样T细胞淋巴瘤、自身免疫性淋巴增殖综合征和家族性噬血细胞性淋巴组织细胞增生症之间的关联
J Cutan Pathol. 2021 Apr;48(4):572-577. doi: 10.1111/cup.13863. Epub 2020 Oct 9.
3
Germline mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.胚系突变及其与皮下脂膜炎样 T 细胞淋巴瘤和噬血细胞性淋巴组织细胞增多症临床谱的关系:多中心研究和荟萃分析的结果。
Haematologica. 2023 Oct 1;108(10):2743-2752. doi: 10.3324/haematol.2022.282419.
4
TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.TIM-3 缺陷表现为两次非克隆相关的肠系膜和皮下脂膜炎样 T 细胞淋巴瘤和噬血细胞性淋巴组织细胞增生症。
Pediatr Blood Cancer. 2020 Jun;67(6):e28302. doi: 10.1002/pbc.28302. Epub 2020 Apr 14.
5
Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation.与胚系 HAVCR2 突变相关的成人噬血细胞性淋巴组织细胞增生症的良好预后。
Exp Hematol. 2023 Sep-Oct;125-126:20-24.e4. doi: 10.1016/j.exphem.2023.07.005. Epub 2023 Jul 19.
6
Ruxolitinib Monotherapy for a Child With HAVCR2 Gene Mutation Associated Subcutaneous Panniculitis-like T-cell Lymphoma: A Case Report.芦可替尼单药治疗 HAVCR2 基因突变相关皮下脂膜炎样 T 细胞淋巴瘤患儿:病例报告
J Pediatr Hematol Oncol. 2024 Jul 1;46(5):e327-e330. doi: 10.1097/MPH.0000000000002868. Epub 2024 May 13.
7
Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in children.芦可替尼治疗 HAVCR2 突变相关噬血细胞性淋巴组织细胞增生症和儿童脂膜炎表现的疗效。
Br J Haematol. 2023 Jul;202(1):135-146. doi: 10.1111/bjh.18817. Epub 2023 Apr 16.
8
Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literature.皮下脂膜炎样 T 细胞淋巴瘤伴噬血细胞性淋巴组织细胞增生症:文献报道的 63 例患者的系统回顾。
Clin Exp Med. 2023 Dec;23(8):4575-4583. doi: 10.1007/s10238-023-01210-1. Epub 2023 Oct 16.
9
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.胚系 HAVCR2 突变改变 TIM-3 特征性表现为伴有噬血细胞性淋巴组织细胞增生症的皮下脂膜炎样 T 细胞淋巴瘤。
Nat Genet. 2018 Dec;50(12):1650-1657. doi: 10.1038/s41588-018-0251-4. Epub 2018 Oct 29.
10
HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma.HAVCR2突变与皮下脂膜炎样T细胞淋巴瘤中的严重噬血细胞综合征相关。
Blood. 2020 Mar 26;135(13):1058-1061. doi: 10.1182/blood.2019003811.

引用本文的文献

1
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents.泰国儿童和青少年伴和不伴胚系 HAVCR2 突变的皮下脂膜炎样 T 细胞淋巴瘤的特征和治疗结果。
Orphanet J Rare Dis. 2024 Nov 13;19(1):426. doi: 10.1186/s13023-024-03438-w.
2
Treatment outcomes between cyclosporin and chemotherapy in adult subcutaneous panniculitis-like T-cell lymphoma: a report from nation-wide Thai lymphoma study group registry.环孢素与化疗治疗成人皮下脂膜炎样T细胞淋巴瘤的疗效比较:泰国淋巴瘤研究组全国登记报告
Ann Hematol. 2024 Dec;103(12):5741-5748. doi: 10.1007/s00277-024-05953-z. Epub 2024 Aug 23.

本文引用的文献

1
Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation.与胚系 HAVCR2 突变相关的成人噬血细胞性淋巴组织细胞增生症的良好预后。
Exp Hematol. 2023 Sep-Oct;125-126:20-24.e4. doi: 10.1016/j.exphem.2023.07.005. Epub 2023 Jul 19.
2
Efficacy of ruxolitinib for HAVCR2 mutation-associated hemophagocytic lymphohistiocytosis and panniculitis manifestations in children.芦可替尼治疗 HAVCR2 突变相关噬血细胞性淋巴组织细胞增生症和儿童脂膜炎表现的疗效。
Br J Haematol. 2023 Jul;202(1):135-146. doi: 10.1111/bjh.18817. Epub 2023 Apr 16.
3
Germline mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.
胚系突变及其与皮下脂膜炎样 T 细胞淋巴瘤和噬血细胞性淋巴组织细胞增多症临床谱的关系:多中心研究和荟萃分析的结果。
Haematologica. 2023 Oct 1;108(10):2743-2752. doi: 10.3324/haematol.2022.282419.
4
JAK inhibitors in difficult-to-treat adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.JAK抑制剂在难治性成人斯蒂尔病和全身型幼年特发性关节炎中的应用
Rheumatology (Oxford). 2023 Apr 3;62(4):1594-1604. doi: 10.1093/rheumatology/keac440.
5
Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression.基于HAVCR2变异且TIM-3表达缺失的噬血细胞性淋巴组织细胞增生症样疾病的治疗
Blood Adv. 2022 Aug 9;6(15):4501-4505. doi: 10.1182/bloodadvances.2022007450.
6
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations.皮下脂膜炎样 T 细胞淋巴瘤的遗传学特征及 HAVCR2 突变的临床病理影响。
Blood Adv. 2021 Oct 26;5(20):3919-3930. doi: 10.1182/bloodadvances.2021004562.
7
TIM-3: An update on immunotherapy.TIM-3:免疫疗法的最新进展。
Int Immunopharmacol. 2021 Oct;99:107933. doi: 10.1016/j.intimp.2021.107933. Epub 2021 Jul 2.
8
Genetics and pathophysiology of haemophagocytic lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症的遗传学和病理生理学。
Acta Paediatr. 2021 Nov;110(11):2903-2911. doi: 10.1111/apa.16013. Epub 2021 Jul 12.
9
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation.TIM-3 通过调节炎症小体激活来抑制抗肿瘤免疫。
Nature. 2021 Jul;595(7865):101-106. doi: 10.1038/s41586-021-03626-9. Epub 2021 Jun 9.
10
Pediatric hemophagocytic lymphohistiocytosis.儿童噬血细胞性淋巴组织细胞增生症。
Blood. 2020 Apr 16;135(16):1332-1343. doi: 10.1182/blood.2019000936.